Published in
Elsevier, European Journal of Cancer, (108), p. 120-128, 2019
DOI: 10.1016/j.ejca.2018.11.028
Links
Tools
Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer
Journal article published in 2019 by
Benjamin P. Levy,
Giuseppe Giaccone,
Benjamin Besse,
Enriqueta Felip,
Marina Chiara Garassino 
,
Manuel Domine Gomez,
Pilar Garrido ,
Bilal Piperdi,
Santiago Ponce-Aix,
Daniel Menezes,
Kyle J. MacBeth,
Alberto Risueño,
Ruta Slepetis,
Xiaoling Wu,
Abderrahim Fandi
and other authors.
,
Manuel Domine Gomez,
Pilar Garrido ,
Bilal Piperdi,
Santiago Ponce-Aix,
Daniel Menezes,
Kyle J. MacBeth,
Alberto Risueño,
Ruta Slepetis,
Xiaoling Wu,
Abderrahim Fandi
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 